Patents by Inventor Lionel Zaske

Lionel Zaske has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190144406
    Abstract: The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2?-benzoyloxy-5?,20-epoxy-1-hydroxy-7?, 10?-dimethoxy-9-oxo-tax-11-ene-13?-yle, and to the preparation thereof.
    Type: Application
    Filed: November 13, 2018
    Publication date: May 16, 2019
    Inventors: Pascal BILLOT, Marielle DUFRAIGNE, Hagit ELMALEH, Fabrice MANGIN, Patricia RORTAIS, Lionel ZASKE, Alexandre GIULIANI
  • Patent number: 10160739
    Abstract: The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2?-benzoyloxy-5?,20-epoxy-1-hydroxy-7?, 10?-dimethoxy-9-oxo-tax-11-ene-13?-yle, and to the preparation thereof.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: December 25, 2018
    Assignee: AVENTIS PHARMA S.A.
    Inventors: Pascal Billot, Marielle Dufraigne, Hagit Elmaleh, Fabrice Mangin, Patricia Rortais, Lionel Zaske, Alexandre Giuliani
  • Publication number: 20180002302
    Abstract: The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2?-benzoyloxy-5?,20-epoxy-1-hydroxy-7?, 10?-dimethoxy-9-oxo-tax-11-ene-13?-yle, and to the preparation thereof
    Type: Application
    Filed: July 11, 2017
    Publication date: January 4, 2018
    Inventors: Pascal BILLOT, Marielle DUFRAIGNE, Hagit ELMALEH, Fabrice MANGIN, Patricia RORTAIS, Lionel ZASKE, Alexandre Giuliani
  • Publication number: 20160318888
    Abstract: The present invention relates to a novel crystalline ethyl acetate solvate form of cabazitaxel or 4?-acetoxy-2?-benzoyloxy-5?,20-epoxy-1?-hydroxy-7?, 10?-dimethoxy-9-oxo-11-taxen-13?-yl(2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and process for preparing the same.
    Type: Application
    Filed: April 7, 2016
    Publication date: November 3, 2016
    Inventors: Eric DIDIER, Nicolas TREMAUDEUX, Lionel ZASKE
  • Patent number: 9309210
    Abstract: The present invention relates to a novel crystalline ethyl acetate solvate form of cabazitaxel or 4?-acetoxy-2?-benzoyloxy-5?,20-epoxy-1?-hydroxy-7?,10?-dimethoxy-9-oxo-11-taxen-13?-yl(2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and process for preparing the same.
    Type: Grant
    Filed: June 11, 2014
    Date of Patent: April 12, 2016
    Assignee: AVENTIS PHARMA S.A.
    Inventors: Eric Didier, Nicolas Tremaudeux, Lionel Zaske
  • Publication number: 20140350272
    Abstract: The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2?-benzoyloxy-5?,20-epoxy-1-hydroxy-7?, 10?-dimethoxy-9-oxo-tax-11-ene-13?-yle, and to the preparation thereof.
    Type: Application
    Filed: August 6, 2014
    Publication date: November 27, 2014
    Inventors: Pascal BILLOT, Marielle DUFRAIGNE, Hagit ELMALEH, Alexandre GIULIANI, Fabrice MANGIN, Patricia RORTAIS, Lionel ZASKE
  • Publication number: 20140343133
    Abstract: The present invention relates to a novel crystalline ethyl acetate solvate form of cabazitaxel or 4?-acetoxy-2?-benzoyloxy-5?,20-epoxy-1?-hydroxy-7?,10?-dimethoxy-9-oxo-11-taxen-13?-yl(2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and process for preparing the same.
    Type: Application
    Filed: June 11, 2014
    Publication date: November 20, 2014
    Inventors: Eric DIDIER, Nicolas TREMAUDEUX, Lionel ZASKE
  • Patent number: 8378128
    Abstract: The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2?-benzoyloxy-5?,20-epoxy-1-hydroxy-7?, 10?-dimethoxy-9-oxo-tax-11-ene-13?-yl, and to the preparation thereof.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: February 19, 2013
    Assignee: Aventis Pharma SA
    Inventors: Pascal Billot, Marielle Dufraigne, Hagit Elmaleh, Alexandre Giuliani, Fabrice Mangin, Patricia Rortais, Lionel Zaske
  • Publication number: 20110144362
    Abstract: The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2?-benzoyloxy-5?,20-epoxy-1-hydroxy-7?, 10?-dimethoxy-9-oxo-tax-11-ene-13?-yl, and to the preparation thereof.
    Type: Application
    Filed: July 16, 2010
    Publication date: June 16, 2011
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Pascal Billot, Marielle Dufraigne, Hagit Elmaleh, Alexandre Giuliani, Fabrice Mangin, Patricia Rortais, Lionel Zaske